Looking for volunteers
Bupivacaine/Epinephrine +Dexamethasone vs. Liposomal Bupivacaine
NCT03906617 · The Cooper Health System · Updated 12 Nov 2021
- What is being tested
- Intercostal nerve block and wound infiltration with liposomal bupivacaine; Intercostal nerve block and wound infiltration with bupivacaine/epinephrine + dexamethasone
- For
- Robotic Lung Surgery
- Kind of study
- Tests a treatment or device on volunteers. Phase 4.
- Who can join
- Ages 18 years to 90 years. About 34 people. The full rules are on the registry page.
- Where
- United States
- When
- Starts or started 10 April 2019, ends 10 June 2022. Registered 8 April 2019.
- Results
- None posted yet.
In the researchers' words
This study will assess analgesia after robotic lung surgery. Subjects will be randomized to receive wound infiltration and intercostal nerve block with either liposomal bupivacaine or bupivacaine/epinephrine + dexamethasone. Liposomal bupivacaine is a newer local anesthetic product and has not been compared to a combination of bupivacaine/epinephrine + dexamethasone in the context of pain control after robotic lung surgery.
Sites
- Cooper University HospitalCamden, New Jersey, United States